Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CCASI PHARMACEUTICALS, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

CASI PHARMACEUTICALS, INC.

$0.13Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $20.71M. Net result −$48.06M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $20.71M. Running result $20.71M. Revenue: $20.71M.
  • Cost of revenue: −$10.64M. Running result $10.08M.
  • Gross profit: $10.08M. Running result $10.08M.
  • Research and development: −$6.31M. Running result $3.77M.
  • General and administrative: −$28.27M. Running result −$24.5M.
  • Selling and marketing: −$18.34M. Running result −$42.85M.
  • Foreign exchange gain (loss): $2.16M. Running result −$40.69M.
  • Other operating costs: −$4.32M. Running result −$45.01M.
  • Operating income: −$45.01M. Running result −$45.01M.
  • Other expense: −$3.05M. Running result −$48.06M.
  • Pre-tax loss: −$48.06M. Running result −$48.06M.
  • Income tax benefit: $0. Running result −$48.06M.
  • Net loss: −$48.06M. Running result −$48.06M.